Drug Shortage Report for LIORESAL INTRATHECAL 0.5MG/ML
| Report ID | 148466 |
| Drug Identification Number | 02131056 |
| Brand name | LIORESAL INTRATHECAL 0.5MG/ML |
| Common or Proper name | LIORESAL 10MG/20ML 1X1 AMPS |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BACLOFEN |
| Strength(s) | 0.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRATHECAL INTRATHECAL |
| Packaging size | 1 X 1 AMPS |
| ATC code | M03BX |
| ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2021-11-05 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2021-11-11 |
| Shortage status | Resolved |
| Updated date | 2022-01-17 |
| Company comments | Delay in product release |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-01-17 | French | Compare |
| v4 | 2022-01-17 | English | Compare |
| v3 | 2021-11-06 | English | Compare |
| v2 | 2021-10-28 | French | Compare |
| v1 | 2021-10-28 | English | Compare |
Showing 1 to 5 of 5